2021 annual financial data

Outlook Therapeutics, Inc. 2021 Operating margin

Outlook Therapeutics, Inc. 2021 operating margin with verified reported values.

Direct answer

Operating margin was Not calculable.

Operating income was -51,727,000 USD and net income was -53,163,000 USD.
Operating cash flow was -54,253,288 USD.

Get free Outlook Therapeutics, Inc. email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
0 USD
Operating income
-51,727,000 USD
Net income
-53,163,000 USD
Operating cash flow
-54,253,288 USD